171 related articles for article (PubMed ID: 28755573)
21. Do bioactive 8-hydroxyquinolines oxidovanadium(IV) and (V) complexes inhibit the growth of M. smegmatis?
Scalese G; Arhouma Z; Kostenkova K; Pérez-Díaz L; Crick DC; Gambino D; Crans DC
J Inorg Biochem; 2022 Dec; 237():111984. PubMed ID: 36152468
[TBL] [Abstract][Full Text] [Related]
22. Desing and synthesis of potent anti-Trypanosoma cruzi agents new thiazoles derivatives which induce apoptotic parasite death.
da Silva EB; Oliveira E Silva DA; Oliveira AR; da Silva Mendes CH; Dos Santos TA; da Silva AC; de Castro MC; Ferreira RS; Moreira DR; Cardoso MV; de Simone CA; Pereira VR; Leite AC
Eur J Med Chem; 2017 Apr; 130():39-50. PubMed ID: 28242550
[TBL] [Abstract][Full Text] [Related]
23. Efficacy of 2-hydroxy-3-phenylsulfanylmethyl-[1,4]-naphthoquinone derivatives against different Trypanosoma cruzi discrete type units: Identification of a promising hit compound.
Lara LS; Moreira CS; Calvet CM; Lechuga GC; Souza RS; Bourguignon SC; Ferreira VF; Rocha D; Pereira MCS
Eur J Med Chem; 2018 Jan; 144():572-581. PubMed ID: 29289882
[TBL] [Abstract][Full Text] [Related]
24. Discovery of 4-((1-(1H-imidazol-2-yl)alkoxy)methyl)pyridines as a new class of Trypanosoma cruzi growth inhibitors.
Ponzi S; Bresciani A; Kaiser M; Nardi V; Nizi E; Ontoria JM; Pace P; Paonessa G; Summa V; Harper S
Bioorg Med Chem Lett; 2020 Apr; 30(8):127052. PubMed ID: 32113841
[TBL] [Abstract][Full Text] [Related]
25. Isoquinoline-based analogs of the cancer drug clinical candidate tipifarnib as anti-Trypanosoma cruzi agents.
Chennamaneni NK; Arif J; Buckner FS; Gelb MH
Bioorg Med Chem Lett; 2009 Dec; 19(23):6582-4. PubMed ID: 19875282
[TBL] [Abstract][Full Text] [Related]
26. Cytotoxic oxidovanadium(IV) complexes of tridentate halogen-substituted Schiff bases: First dinuclear V(IV) complexes with O → V
Rudbari HA; Saadati A; Aryaeifar M; Correia I; Marques F; Blacque O; Micale N
Bioorg Med Chem Lett; 2021 Oct; 49():128285. PubMed ID: 34303813
[TBL] [Abstract][Full Text] [Related]
27. Strategies for overcoming tropical disease by ruthenium complexes with purine analog: Application against Leishmania spp. and Trypanosoma cruzi.
Fandzloch M; Arriaga JMM; Sánchez-Moreno M; Wojtczak A; Jezierska J; Sitkowski J; Wiśniewska J; Salas JM; Łakomska I
J Inorg Biochem; 2017 Nov; 176():144-155. PubMed ID: 28910663
[TBL] [Abstract][Full Text] [Related]
28. 2-Pyridyl thiazoles as novel anti-Trypanosoma cruzi agents: structural design, synthesis and pharmacological evaluation.
Cardoso MV; de Siqueira LR; da Silva EB; Costa LB; Hernandes MZ; Rabello MM; Ferreira RS; da Cruz LF; Moreira DR; Pereira VR; de Castro MC; Bernhardt PV; Leite AC
Eur J Med Chem; 2014 Oct; 86():48-59. PubMed ID: 25147146
[TBL] [Abstract][Full Text] [Related]
29. In vitro and in vivo antiparasital activity against Trypanosoma cruzi of three novel 5-methyl-1,2,4-triazolo[1,5-a]pyrimidin-7(4H)-one-based complexes.
Caballero AB; Marín C; Rodríguez-Diéguez A; Ramírez-Macías I; Barea E; Sánchez-Moreno M; Salas JM
J Inorg Biochem; 2011 Jun; 105(6):770-6. PubMed ID: 21497152
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of NAD+-dependent histone deacetylases (sirtuins) causes growth arrest and activates both apoptosis and autophagy in the pathogenic protozoan Trypanosoma cruzi.
Veiga-Santos P; Reignault LC; Huber K; Bracher F; De Souza W; De Carvalho TM
Parasitology; 2014 May; 141(6):814-25. PubMed ID: 24670415
[TBL] [Abstract][Full Text] [Related]
31. Activity on Trypanosoma cruzi, erythrocytes lysis and biologically relevant physicochemical properties of Pd(II) and Pt(II) complexes of thiosemicarbazones derived from 1-indanones.
Santos D; Parajón-Costa B; Rossi M; Caruso F; Benítez D; Varela J; Cerecetto H; González M; Gómez N; Caputto ME; Moglioni AG; Moltrasio GY; Finkielsztein LM; Gambino D
J Inorg Biochem; 2012 Dec; 117():270-6. PubMed ID: 23063173
[TBL] [Abstract][Full Text] [Related]
32. Analogues of fenarimol are potent inhibitors of Trypanosoma cruzi and are efficacious in a murine model of Chagas disease.
Keenan M; Abbott MJ; Alexander PW; Armstrong T; Best WM; Berven B; Botero A; Chaplin JH; Charman SA; Chatelain E; von Geldern TW; Kerfoot M; Khong A; Nguyen T; McManus JD; Morizzi J; Ryan E; Scandale I; Thompson RA; Wang SZ; White KL
J Med Chem; 2012 May; 55(9):4189-204. PubMed ID: 22536986
[TBL] [Abstract][Full Text] [Related]
33. Zinc 1,2,4-triazolo[1,5-a]pyrimidine Complexes: Synthesis, Structural Characterization and their Effect Against Chagas Disease.
Méndez-Arriaga JM; Rubio-Mirallas E; Quirós M; Sánchez-Moreno M
Med Chem; 2022; 18(4):444-451. PubMed ID: 34387166
[TBL] [Abstract][Full Text] [Related]
34. Trypanosoma cruzi biochemical changes and cell death induced by an organometallic platinum-based compound.
Mosquillo MF; Bilbao L; Hernández F; Tissot F; Gambino D; Garat B; Pérez-Díaz L
Chem Biol Drug Des; 2018 Sep; 92(3):1657-1669. PubMed ID: 29745031
[TBL] [Abstract][Full Text] [Related]
35. Antiprotozoal drug nitazoxanide enhances parasitemia, tissue lesions and mortality caused by Trypanosoma cruzi in murine model.
Valle-Reyes JS; Melnikov V; Dobrovinskaya O; Rodriguez-Hernández A; Wookee-Zea C; Pimientel-Rodrigez V; Rueda-Valdovinos G; Delgado-Enciso I; López-Lemus UA; Espinoza-Gómez F
Exp Parasitol; 2017 Jan; 172():44-50. PubMed ID: 28011170
[TBL] [Abstract][Full Text] [Related]
36. Activity of "reversed" diamidines against Trypanosoma cruzi "in vitro".
Silva CF; Batista MM; Mota RA; de Souza EM; Stephens CE; Som P; Boykin DW; Soeiro Mde N
Biochem Pharmacol; 2007 Jun; 73(12):1939-46. PubMed ID: 17462605
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and biological evaluation of quinones derived from natural product komaroviquinone as anti-Trypanosoma cruzi agents.
Suto Y; Nakajima-Shimada J; Yamagiwa N; Onizuka Y; Iwasaki G
Bioorg Med Chem Lett; 2015 Aug; 25(15):2967-71. PubMed ID: 26037321
[TBL] [Abstract][Full Text] [Related]
38. In vitro and in vivo trypanocidal evaluation of nickel complexes with an azapurine derivative against Trypanosoma cruzi.
Maldonado CR; Marín C; Olmo F; Huertas O; Quirós M; Sánchez-Moreno M; Rosales MJ; Salas JM
J Med Chem; 2010 Oct; 53(19):6964-72. PubMed ID: 20812723
[TBL] [Abstract][Full Text] [Related]
39. Copper(I)-Thiosemicarbazone Complexes with Dual Anticancer and Antiparasitic Activity.
Machado JF; Marques F; Pinheiro T; Villa de Brito MJ; Scalese G; Pérez-Díaz L; Otero L; António JPM; Gambino D; Morais TS
ChemMedChem; 2023 Jul; 18(14):e202300074. PubMed ID: 37098105
[TBL] [Abstract][Full Text] [Related]
40. Synthesis, in vitro antitrypanosomal and antibacterial activity of phenoxy, phenylthio or benzyloxy substituted quinolones.
Ma X; Zhou W; Brun R
Bioorg Med Chem Lett; 2009 Feb; 19(3):986-9. PubMed ID: 19095449
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
